| Literature DB >> 26442121 |
Haifeng Ma1, Xia Liu2, Ying Wu1, Naixia Zhang2.
Abstract
In this study, the antifatigue effects of acupuncture had been investigated at the metabolic level on the young male athletes with exhaustive physical exercises. After a series of exhaustive physical exercises and a short-term rest, the athletes either were treated with needling acupuncture on selected acupoints (TA group) or enjoyed an extended rest (TR group). NMR-based metabolomics analysis was then applied to depict the metabolic profiles of urine samples, which were collected from the athletes at three time points including the time before exercises, the time before and after the treatment of acupuncture, or taking the extended rest. The results from multivariate statistical analysis indicated that the recoveries of disturbed metabolites in the athletes treated with acupuncture were significantly faster than in those only taking rest. After the treatment with acupuncture, the levels of distinguished metabolites, 2-hydroxybutyrate, 3-hydroxyisovalerate, lactate, pyruvate, citrate, dimethylglycine, choline, glycine, hippurate, and hypoxanthine were recovered at an accelerated speed in the TA group in comparison with the TR group. The above-mentioned results indicated that the acupuncture treatment ameliorated fatigue by backregulating the perturbed energy metabolism, choline metabolism, and attenuating the ROS-induced stress at an accelerated speed, which demonstrated that acupuncture could serve as an alternative fatigue-relieving approach.Entities:
Year: 2015 PMID: 26442121 PMCID: PMC4579316 DOI: 10.1155/2015/508302
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.629
Figure 1The design of the exercise session. Blocks depict 8000-meter, 500-meter, and 100-meter runs, and arrows indicate urine sampling. Min is the abbreviation of minutes.
Figure 2Scores plots of PCA (a), PLS-DA (b), and OPLS-DA (c) derived from 1H NMR data of TA, TR, and T0 groups. Variables of scores plots are centered and scaled.
Figure 3OPLS-DA scores plots of 1H NMR data, ROC maps, and OPLS-DA coefficient plots of 1H NMR data derived from PLS-DA models of T35 versus T0 groups (a, a′, and a′′), T35 versus T0 groups (b, b′, and b′′) with lactate excluded, and TA versus TR group (c, c′, and c′′). The abbreviations of metabolites are denoted in Table S1 as shown in the Supplementary Material.
The change trends of discriminitive metabolites between groups.
| Metabolites |
| % average changes in TA relatively to TR (| | % average changes in T35 relatively to T0 (| | % average changes in T35 relatively to T0 (| | % average changes in TA relatively to T0 (| | % average changes in TR relatively to T0 (| |
|---|---|---|---|---|---|---|
| 2HB | 0.90 | −19.3 (0.46, 0.24, 0.10) | +242.2 (0.93, 2.81, 0.00) | / | +20.4 (0.67, 0.20, 0.00) | +49.2 (0.81, 0.42, 0.02) |
| Leu | 0.95 | / | +31.3 (0.91, 1.36, 0.00) | / | / | / |
| IB | 1.08 | / | +27.4 (0.70, 1.20, 0.02) | / | / | / |
| 3AIB | 1.20 | −43.1 (0.20, 2.08, 0.16) | / | / | −17.6 (0.18, 1.12, 0.73) | +44.9 (0.22, 1.44, 0.46) |
| 3HIV | 1.24 | +5.6 (0.66, 1.80, 0.28) | −56.5 (0.56, 1.47, 0.00) | / | +2.9 (0.28, 1.47, 0.80) | −2.6 (0.23, 0.97, 0.78) |
| Lac | 1.34 | −46.4 (0.56, 16.2, 0.03) | / | +7770.5 (0.97, 27.9, 0.00) | +456.5 (0.90, 19.2, 0.00) | +932.2 (0.72, 25.3, 0.00) |
| Ala | 1.48 | / | +56.0 (0.50, 1.84, 0.02) | / | −26.4 (0.60, 1.30, 0.19) | −14.7 (0.24, 1.16, 0.23) |
| Pyr | 2.35 | +73.7 (0.43, 2.36, 0.07) | −20.0 (0.26, 1.07, 0.17) | / | +32.7 (0.27, 1.35, 0.20) | −23.6 (0.21, 0.53, 0.15) |
| Suc | 2.38 | / | +1434.8 (0.91, 30.0, 0.00) | / | +124.2 (0.90, 2.03, 0.00) | +121.4 (0.88, 1.38, 0.01) |
| Gln | 2.45 | / | −25.7 (0.72, 1.69, 0.00) | / | −23.4 (0.61, 1.21, 0.01) | −14.5 (0.44, 0.79, 0.12) |
| Cit | 2.55 | +52.5 (0.48, 1.88, 0.07) | −64.0 (0.68, 8.26, 0.00) | / | −33.6 (0.54, 4.97, 0.04) | −56.5 (0.56, 6.07, 0.00) |
| DMA | 2.72 | −14.7 (0.45, 1.06, 0.02) | −6.6 (0.36, 0.99, 0.18) | / | −2.2 (0.29, 0.48, 0.35) | +14.7 (0.18, 0.70, 0.10) |
| DMG | 2.93 | +11.2 (0.09, 0.32, 0.26) | −29.8 (0.48, 1.83, 0.000) | −10.4 (0.42, 0.67, 0.21) | −19.5 (0.34, 0.84, 0.04) | |
| Crn | 3.04 | −6.2 (0.67, 25.9, 0.04) | / | +3.9 (0.07, 8.26, 0.20) | −3.5 (0.06, 4.89, 0.23) | +2.9 (0.03, 10.5, 0.292) |
| Cho | 3.21 | +83.9 (0.17, 2.68, 0.12) | −3.6 (0.06, 0.26, 0.34) | / | +167.8 (0.44, 3.59, 0.06) | +45.6 (0.46, 1.30, 0.07) |
| TMAO | 3.27 | −18.4 (0.19, 1.25, 0.10) | −31.5 (0.51, 3.63, 0.03) | / | −24.8 (0.25, 7.56, 0.09) | −7.8 (0.20, 4.02, 0.33) |
| Tau | 3.43 | −37.3 (0.24, 1.52, 0.08) | −28.5 (0.47, 1.23, 0.02) | / | +3.4 (0.23, 0.61, 0.44) | +64.9 (0.33, 2.22, 0.07) |
| Gly | 3.57 | +14.9 (0.33, 1.12, 0.11) | −60.0 (0.82, 17.2, 0.000) | −60.0 (0.82, 17.2, 0.000) | −53.0 (0.74, 11.98, 0.00) | −59.1 (0.43, 11.87, 0.00) |
| Hip | 7.83 | +176.2 (0.75, 3.17, 0.01) | −21.7 (0.17, 0.99, 0.26) | / | −18.8 (0.08, 0.31, 0.28) | −70.6 (0.33, 3.66, 0.01) |
| Hyx | 8.19 | −46.2 (0.55, 1.02, 0.01) | +2000.0 (0.87, 4.49, 0.00) | / | +648.9 (0.79, 1.23, 0.02) | +1292.6 (0.78, 2.54, 0.00) |
| For | 8.46 | / | −69.6 (0.57, 1.64, 0.00) | / | −48.0 (0.51, 0.95, 0.01) | −57.7 (0.45, 0.92, 0.00) |
“+” means an increase.
“−” means a decrease.
“/” means no significant change (|r| < the cut-off value, VIP < 1 and/or p ≥ 0.05).
aThe absolute values of correlation number extracted from the correlation plots of OPLS-DA models. The cut-off values are 0.532 in the coefficient plot of TA versus TR, 0.404 in the coefficient plot of T35 versus T0, and 0.433 in the coefficient plot of TA versus T0 and TR versus T0.
bThe p values were obtained from one-way ANOVA.
Figure 4Potential metabolic pathways disturbed in the T35 group and altered in the TA and TR groups. The level changes of significant metabolites were depicted by their respective box chart.